Peregrine Pharmaceuticals shares owned by Lindbrook Capital
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Lindbrook Capital
from 13F filings
Historical chart of Lindbrook Capital investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by Lindbrook Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $1.6k | 240 | 6.70 |
| 2023-12-31 | $1.6k | 240 | 6.50 |
| 2023-09-30 | $0 | 0 | 0.00 |
| 2023-06-30 | $349 | 25 | 13.96 |
| 2022-09-30 | $0 | 25 | 0.00 |